Argos Therapeutics IPO Advisory

IPO Research - IPO Boutique

<< Return Home

Subscribe Now
  IPO Boutique Blog
IPO Central
  IPO Calendar
  IPO Pipeline
  Track Record
  Last 10 IPO's & Quotes
  Sample IPO
  Rating Scale
  IPO Primer
Secondaries
  Current Week
  Track Record
  2015 Secondaries
  2014 Secondaries
  2013 Secondaries
  2012 Secondaries
  2011 Secondaries
  2010 Secondaries
  Secondaries Primer
Media
International publications
quoting IPO Boutique
founder Scott Sweet
General Info
  About Us
  Contact Us
  Testimonials
  Announcements
  Disclaimer
  Site Map
  A Touch of Humor



For IPO Boutique's "scale of 1 to 5" BUY rating on Argos Therapeutics, and our comprehensive analysis, click the "Buy Market Research" link.
Company
Symbol
Price Range
Open
Shares
Trade Date
Argos TherapeuticsARGS
[ Nasdaq ]
Priced at $8.00 $8.905.63 million2/7/2014
Underwriter(s):
Piper Jaffray, Stifel, JMP Securities
Co-Manager(s):
Needham & Co.

About Argos Therapeutics (adapted from Argos Therapeutics prospectus):
Argos is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on their proprietary technology platform called Arcelis. Using biological components obtained from each patient, their Arcelis-based immunotherapies employ a specialized white blood cell, called a dendritic cell, to activate an immune response that is specific to the patient's disease.

This description is adapted from Argos prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus..


Share this IPO Profile:

IPO Boutique aggregates information on public companies and private companies, such as Argos "ARGS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.



Need a recommendation? Visit our Testimonials page and see over 200 investors singing our praises.



Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2015 IPO Boutique. All Rights Reserved